Influence of direct stenting on the frequency of intraoperative complications and immediate treatment outcomes in patients with ST-elevation myocardial infarction
Authors:
Company:
1 Stavropol Regional Clinical Hospital, Stavropol, Russian Federation
2 RUDN University Moscow, Russian Federation
For correspondence: Sign in or register.
Type: Original articles
DOI:
For citation: Sazanov G.V., Shugushev Z.Kh., Belokon O.S., Ermakov S.V., Pisarenko N.V. Influence of direct stenting on the frequency of intraoperative complications and immediate treatment outcomes in patients with STEMI. Creative Cardiology. 2023; 17 (3): 424–32 (in Russ.). DOI: 10.24022/1997-3187-2023-17-3-424-432
Received / Accepted: 25.08.2023 / 18.09.2023
Keywords: ST-elevation myocardial infarction percutaneous coronary phases no-reflow/slow-reflow phenomenon
Abstract
Objective. To evaluate the immediate results of primary percutaneous coronary intervention in patients with STelevation myocardial infarction (STEMI) with preserved antegrade blood flow, depending on the performance of balloon predilatation before coronary stent implantation or direct stenting.
Material and methods. The study included 326 patients with STEMI and preserved antegrade blood flow (TIMI 1–3) during coronary angiography. The patients were divided into 2 groups: the first included 108 patients who underwent balloon predilatation before implantation of a coronary stent, and the second included 218 patients who underwent direct stenting of the infarct-associated coronary artery.
Results. The study found that direct stenting in patients with STEMI was characterized by a statistically significantly lower risk of slow- and no-reflow phenomenon (p=0.001, Pearson’s Chi-square) and, as a result, better functional outcomes of treatment of patients (the degree of chronic heart failure according to N.D. Strazhesko, V.Kh. Vasilenko and left ventricular ejection fraction), which were also statistically significant (p=0.001, Pearson’s Chi-square).
Conclusion. Direct stenting was a more favorable effect on the treatment outcomes of patients with STEMI, restoration of the contractile function of the left ventricle, and immediate clinical outcomes and can be considered in patients with STEMI and preserved antegrade blood flow (TIMI 1–3) as the method of choice for PCI in patients with STEMI.
References
- Alekyan B.G. Endovascular surgery. National leadership. In 4 vols. Moscow; 2017. Vol. 2: 399–426 (in Russ.).
- Sazanov G.V., Belokon O.S. The effect of predilation on the incidence of the no/slow-reflow phenomenon in patients with acute coronary syndrome with ST segment elevation. Kazan Medical Journal. 2020; 101 (2): 284–8 (in Russ.). DOI: 10.17816/KMJ2020-284
- Niccoli G., Ibanez B., Thiele H., Thiele H., Crea F., Heusch G. et al. Optimized treatment of ST-elevation myocardial infarction. Circ. Res. 2019; 125: 245–58. DOI: 10.1161/CIRCRESAHA.119.315344
- Коваль М. Феномен «no-reflow» – ложка дегтя в бочке меда реваскуляризации. Med. Review. 2008; 5: 32–6. Koval M. “No-reflow” phenomenon – a fly in the ointment of revascularization. Medicine Review. 2008; 5: 32–6 (in Russ.).
- Sazanov G.V., Shugushev Z.Kh., Belokon O.S., Ermakov S.V., Khripunova A.A. Dilation of the infarct-related coronary artery to reduce the incidence of the no-reflow phenomenon in STEMI patients. Innovative Medicine of Kuban. 2023; 3: 54–61 (in Russ.). DOI: 10.35401/2541-9897-2023-26-3-54-61
- Iskhakov M.M., Tagirova D.R., Gazizov N.V., NugaybekovaL.A., Sayfutdinov R.G. «No-reflow» phenomenon: clinical aspects of reperfusion failure. Kazan Medical Journal. 2015; 96 (3): 391–6 (in Russ.). DOI: 10.17750/KMJ2015-391
- Yaméogo N.V., Guenancia C., Porot G., Richard C., GudjoncikA. et al. Predictors of angiographically visible distal embolization in STEMI. Herz. 2020; 45 (3): 288–92. DOI: 10.1007/s00059-018-4723-1
- Remkes W.S., Somi S., Roolvink V., Rasoul S., Ottervanger J.P., Gosselink A.T.M. Direct drug-eluting stenting to reduce stent restenosis: a randomized comparison of direct stent implantation to conventional stenting with pre-dilation or provisional stenting in elective PCI patients. JACC Cardiovasc. Interv. 2014; 7 (7): 751–8. DOI: 10.1016/j.jcin.2014.02.012
- Namazi M., Mahmoudi E., Safi E., Jenab Y., Vakili H., Saadat H. et al. The No-reflow phenomenon: is it predictable by demographic factors and routine laboratory data? Acta. Biomed. 2021; 92 (5): 1202–97. DOI: 10.23750/abm.v92i5.10053
- Stiermaier S.M.T., Fuernau G., Pöss J., Waha-Thiele S., Desch S. et al. Impact of direct stenting on myocardial injury assessed by cardiac magnetic resonance imaging and prognosis in STelevation myocardial infarction. Int. J. Cardiol. 2019; 283: 88– 92. DOI: 10.1016/j.ijcard.2018.11.141
- Ibanez B., James S., Agewall S., Antunes M.J., BucciarelliDucci C., Bueno H. et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur. Heart J. 2018; 39: 119–77. DOI: 10.1016/j.rec.2017.11.010
- Kim B.G., Cho S.W., Seo J., Kim G.S., Jin M.N., Lee H.Y. et al. Effect of direct stenting on microvascular dysfunction during percutaneous coronary intervention in acute myocardial infarction: a randomized pilot study. J. Int. Med. Res. 2022; 50 (9): 1–9. DOI: 10.1177/03000605221127888
- Jolly S.S., Cairns J.A., Yusuf S., Meeks B., Pogue J., Rokoss M.J. et al. Randomized trial of primary PCI with or without routine manual thrombectomy. N. Engl. J. Med. 2015; 372: 1389–98. DOI: 10.1056/NEJMoa1415098
- Loubeyre C., Morice M.C., Lefevre T., Piéchaud J.-F., Louvard Y., Dumas P. et al. A randomized comparison of direct stenting with conventional stent implantation in selected patients with acute myocardial infarction. J. Am. Coll. Cardiol. 2002; 39: 15–21. DOI: 10.1016/s0735-1097(01)01701-6
- Sabatier R., Hamon M., Zhao Q.M., Burzotta F., Lecluse E., Valette B., Grollier G. Could direct stenting reduce noreflow in acute coronary syndromes? A randomized pilot study. Am. Heart J. 2002; 143: 1027–32. DOI: 10.1067/mhj.2002.122509
- Ballarino M.A., Moreyra E., Jr., Damonte A., Sampaolesi A., Woodfield S., Pacheco G. et al. Multicenter randomized comparison of direct vs. conventional stenting: the DIRECTO trial. Catheter. Cardiovasc. Interv. 2003; 58: 434–40. DOI: 10.1002/ccd.10404
- Gasior M., Gierlotka M., Lekston A., Wilczek K., Zebik T., Hawranek M. et al. Comparison of outcomes of direct stenting versus stenting after balloon predilation in patients with acute myocardial infarction (DIRAMI). Am. J. Cardiol. 2007; 100: 798–805. DOI: 10.1016/j.amjcard.2007.04.026
- Ozdemir R., Sezgin A.T., Barutcu I., Topal E., Gullu H., Acikgoz N. et al. Comparison of direct stenting versus conventional stent implantation on blood flow in patients with ST-segment elevation myocardial infarction. Angiology. 2006; 57: 453–8. DOI: 10.1177/0003319706290620
- Alak A., Lugomirski P., Aleksova N., Jolly S.S. A meta-analysis of randomized controlled trials of conventional stenting versus direct stenting in patients with acute myocardial infarction. J. Inv. Cardiol. 2015; 27: 405–9.
- Annibali G., Scrocca I., Aranzulla T.C., Meliga E., Maiellaro F., Musumeci G. et al. “No-Reflow” phenomenon: a contemporary review. J. Clin. Med. 2022; 11: 2233. DOI: 10.3390/jcm11082233
About Authors
- Grigoriy V. Sazanov, Endovascular Surgeon; ORCID
- Zaurbek Kh. Shugushev, Dr. Med. Sci., Associate Professor, Chief of Chair; ORCID
- Oleg S. Belokon, Cand. Med. Sci., Head of Department, Endovascular Surgeon; ORCID
- Sergey V. Ermakov, Cand. Med. Sci., Neurologist, Endovascular Surgeon; ORCID
- Nikolay V. Pisarenko, Endovascular Surgeon; ORCID